Thus, it remains unclear whether CD69+CD103+T cells are true TRM cells or alternately the expression of these molecules identifies effector T-cell subsets that have infiltrated the tumor bed where abundant TGF-β found in a large quantity in many tumors drives CD103 expression. This evidence concerns the gene CD69 and neoplasm.